Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 27 February, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo

CreditAccess Grameen Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: February 27, 2025, 2:52 pm

Market Cap 16,099 Cr.
Current Price 1,009
High / Low 1,553/750
Stock P/E18.3
Book Value 438
Dividend Yield0.94 %
ROCE14.8 %
ROE24.8 %
Face Value 10.0
PEG Ratio0.67

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for CreditAccess Grameen Ltd

Competitors of CreditAccess Grameen Ltd

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Muthoot Microfin Ltd 2,294 Cr. 135 258/1317.69 1760.00 %15.0 %20.4 % 10.0
Satin Creditcare Network Ltd 1,631 Cr. 148 275/1345.58 2300.00 %16.6 %21.6 % 10.0
CreditAccess Grameen Ltd 16,099 Cr. 1,009 1,553/75018.3 4380.94 %14.8 %24.8 % 10.0
Industry Average6,674.67 Cr430.6710.52281.330.31%15.47%22.27%10.00

All Competitor Stocks of CreditAccess Grameen Ltd

Quarterly Result

MetricDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Revenue4406075105105766946218129081,0651,1701,2471,292
Interest 179186196183192217226273314346385424442
Expenses 351317268224206267209299293311309342365
Financing Profit-9110446103177210186240301409477481486
Financing Margin %-21%17%9%20%31%30%30%30%33%38%41%39%38%
Other Income 0210100221113
Depreciation 5766677131312121213
Profit before tax -95994197172203179229290398465469476
Tax % 25%27%27%26%25%25%26%24%26%25%26%26%26%
Net Profit -72723072129151133175216297346349353
EPS in Rs -4.614.651.904.628.299.718.5011.2213.8218.9822.1621.9522.20
Gross NPA %6.84%4.38%8.12%7.18%5.50%3.12%1.73%1.48%0.89%0.77%
Net NPA %0.47%0.27%0.24%

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for CreditAccess Grameen Ltd based on the most recent figures (Dec 2023) and their trends compared to the previous period:

  • For Interest, as of Dec 2023, the value is ₹442.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹424.00 Cr. (Sep 2023) to ₹442.00 Cr., marking an increase of ₹18.00 Cr..
  • For Expenses, as of Dec 2023, the value is ₹365.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹342.00 Cr. (Sep 2023) to ₹365.00 Cr., marking an increase of ₹23.00 Cr..
  • For Other Income, as of Dec 2023, the value is ₹3.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.00 Cr. (Sep 2023) to ₹3.00 Cr., marking an increase of ₹2.00 Cr..
  • For Depreciation, as of Dec 2023, the value is ₹13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹12.00 Cr. (Sep 2023) to ₹13.00 Cr., marking an increase of ₹1.00 Cr..
  • For Profit before tax, as of Dec 2023, the value is ₹476.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹469.00 Cr. (Sep 2023) to ₹476.00 Cr., marking an increase of ₹7.00 Cr..
  • For Tax %, as of Dec 2023, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2023) which recorded 26.00%.
  • For Net Profit, as of Dec 2023, the value is ₹353.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹349.00 Cr. (Sep 2023) to ₹353.00 Cr., marking an increase of ₹4.00 Cr..
  • For EPS in Rs, as of Dec 2023, the value is ₹22.20. The value appears strong and on an upward trend. It has increased from ₹21.95 (Sep 2023) to ₹22.20, marking an increase of ₹0.25.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MetricMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Revenue62881462784647088711,2821,6832,0282,6693,4874,241
Interest 3042721292083173544175757459871,2161,413
Expenses 323950761262641843616391,0691,2351,1791,190
Financing Profit-1724741301283325044702144471,0921,638
Financing Margin %-1%7%16%26%28%18%38%39%28%11%17%31%39%
Other Income 022321111381643
Depreciation 111234582023475045
Profit before tax -2825751301243284984511944811,1051,596
Tax % -70%-5%33%35%36%35%35%35%27%27%27%25%
Net Profit -38174983802123223281423538261,189
EPS in Rs -1.172.003.146.6811.419.3716.5422.4122.759.1522.6552.8775.73
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2012-20132013-20142014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-2023
YoY Net Profit Growth (%)366.67%112.50%188.24%69.39%-3.61%165.00%51.89%1.86%-56.71%148.59%133.99%
Change in YoY Net Profit Growth (%)0.00%-254.17%75.74%-118.85%-73.00%168.61%-113.11%-50.02%-58.57%205.30%-14.60%

CreditAccess Grameen Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.

Growth

Compounded Sales Growth
10 Years:43%
5 Years:32%
3 Years:36%
TTM:22%
Compounded Profit Growth
10 Years:56%
5 Years:35%
3 Years:117%
TTM:-35%
Stock Price CAGR
10 Years:%
5 Years:3%
3 Years:9%
1 Year:-34%
Return on Equity
10 Years:16%
5 Years:15%
3 Years:18%
Last Year:25%

Last Updated: Unknown

Balance Sheet

Last Updated: January 13, 2025, 3:52 pm

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 4053737386128144144156156159159159
Reserves 711543033876051,3092,2222,5253,4794,0114,9486,4116,829
Borrowings 3898051,2912,2332,6683,6234,8677,8238,78112,92116,31221,84119,154
Other Liabilities 44466011520553126170281394439435470
Total Liabilities 5431,0581,7272,8083,5645,1147,35710,66212,69717,48221,85828,84626,612
Fixed Assets 3341112162587101629599609628
CWIP 0020312313450
Investments 000000066166314551,4391,303
Other Assets 5401,0551,7202,7963,5495,0967,3309,91111,93216,84920,80126,79424,682
Total Assets 5431,0581,7272,8083,5645,1147,35710,66212,69717,48221,85828,84626,612

Below is a detailed analysis of the balance sheet data for CreditAccess Grameen Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹159.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹159.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹6,829.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6,411.00 Cr. (Mar 2024) to ₹6,829.00 Cr., marking an increase of ₹418.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹19,154.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from ₹21,841.00 Cr. (Mar 2024) to ₹19,154.00 Cr., marking a decrease of ₹2,687.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹470.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹435.00 Cr. (Mar 2024) to ₹470.00 Cr., marking an increase of ₹35.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹26,612.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹28,846.00 Cr. (Mar 2024) to ₹26,612.00 Cr., marking a decrease of ₹2,234.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹628.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹609.00 Cr. (Mar 2024) to ₹628.00 Cr., marking an increase of ₹19.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹5.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of ₹5.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹1,303.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,439.00 Cr. (Mar 2024) to ₹1,303.00 Cr., marking a decrease of ₹136.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹24,682.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹26,794.00 Cr. (Mar 2024) to ₹24,682.00 Cr., marking a decrease of ₹2,112.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹26,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹28,846.00 Cr. (Mar 2024) to ₹26,612.00 Cr., marking a decrease of ₹2,234.00 Cr..

However, the Borrowings (₹19,154.00 Cr.) are higher than the Reserves (₹6,829.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-931-425-1,726-1,378-2,302-364-2,713-3,290-4,734
Cash from Investing Activity +-4-554-7-636-32-33-314-994
Cash from Financing Activity +9345791,4701,8292,9291,7061,9673,3655,494
Net Cash Flow-1149-202444-91,310-780-239-234

Free Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow32.00-350.00-755.0075.00124.00262.00181.00357.00632.00-7.00-11.00-15.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROE %10%10%17%20%14%20%17%13%5%9%18%25%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters73.85%73.82%73.74%73.71%73.68%66.77%66.69%66.66%66.58%66.56%66.54%66.50%
FIIs8.24%8.67%9.33%9.60%9.67%9.55%11.46%12.00%11.65%10.88%10.76%9.76%
DIIs10.94%10.75%12.68%12.53%12.27%11.90%15.78%15.79%15.76%16.25%14.86%14.17%
Public6.97%6.76%4.25%4.16%4.38%11.77%6.08%5.57%6.01%6.31%7.83%9.57%
No. of Shareholders34,56834,14239,64540,89141,97940,62251,17257,98969,82483,6031,03,9281,25,004

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Axis Small Cap Fund1,642,9571.34216.13479,8982025-02-25242.36%
PGIM India Midcap Opportunities Fund1,036,7001.46136.38479,8982025-02-25116.03%
Axis Business Cycles Fund762,9263.96100.36479,8982025-02-2558.98%
UTI Mid Cap Fund635,4090.9383.59479,8982025-02-2532.41%
Tata Mid Cap Growth Fund - Regular Plan500,0002.6165.78479,8982025-02-254.19%
Edelweiss Balanced Advantage Fund485,5770.6763.88479,8982025-02-251.18%
Edelweiss Mid Cap Fund479,8981.6663.13479,8982025-02-250%
SBI Magnum Equity ESG Fund446,0731.1758.68479,8982025-02-25-7.05%
PGIM India Flexi Cap Fund427,9000.9756.29479,8982025-02-25-10.84%
UTI Small Cap Fund420,1471.7455.27479,8982025-02-25-12.45%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 90.8852.0423.318.9623.20
Diluted EPS (Rs.) 90.4151.8223.228.9023.00
Cash EPS (Rs.) 93.9355.1225.9411.2824.71
Book Value[Excl.RevalReserv]/Share (Rs.) 412.22321.37261.50244.01197.46
Book Value[Incl.RevalReserv]/Share (Rs.) 412.22321.37261.50244.01197.46
Revenue From Operations / Share (Rs.) 324.17223.09175.97158.18118.36
PBDIT / Share (Rs.) 233.58149.0297.0174.1273.64
PBIT / Share (Rs.) 230.37145.8993.9871.2972.22
PBT / Share (Rs.) 121.6769.5630.8411.6032.06
Net Profit / Share (Rs.) 90.7251.9822.918.4523.30
NP After MI And SOA / Share (Rs.) 90.7251.9823.298.6123.16
PBDIT Margin (%) 72.0566.7955.1346.8562.21
PBIT Margin (%) 71.0665.3953.4045.0661.01
PBT Margin (%) 37.5331.1817.527.3327.08
Net Profit Margin (%) 27.9823.3013.015.3319.68
NP After MI And SOA Margin (%) 27.9823.3013.235.4419.57
Return on Networth / Equity (%) 22.0016.179.123.6312.19
Return on Capital Employeed (%) 55.2744.8926.0519.7627.58
Return On Assets (%) 5.013.772.080.882.64
Long Term Debt / Equity (X) 0.000.000.370.480.32
Total Debt / Equity (X) 3.323.193.252.963.49
Asset Turnover Ratio (%) 0.200.180.150.160.18
Current Ratio (X) 1.261.261.411.521.35
Quick Ratio (X) 1.261.261.411.521.35
Interest Coverage Ratio (X) 2.151.951.541.241.83
Interest Coverage Ratio (Post Tax) (X) 1.831.681.361.141.58
Enterprise Value (Cr.) 43473.0429417.6824491.8418992.6413802.88
EV / Net Operating Revenue (X) 8.418.308.937.728.10
EV / EBITDA (X) 11.6812.4216.2016.4713.02
MarketCap / Net Operating Revenue (X) 4.444.104.834.242.86
Price / BV (X) 3.492.853.332.831.78
Price / Net Operating Revenue (X) 4.444.104.834.242.86
EarningsYield 0.060.050.020.010.06

After reviewing the key financial ratios for CreditAccess Grameen Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 90.88. This value is within the healthy range. It has increased from 52.04 (Mar 23) to 90.88, marking an increase of 38.84.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 90.41. This value is within the healthy range. It has increased from 51.82 (Mar 23) to 90.41, marking an increase of 38.59.
  • For Cash EPS (Rs.), as of Mar 24, the value is 93.93. This value is within the healthy range. It has increased from 55.12 (Mar 23) to 93.93, marking an increase of 38.81.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 412.22. It has increased from 321.37 (Mar 23) to 412.22, marking an increase of 90.85.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 412.22. It has increased from 321.37 (Mar 23) to 412.22, marking an increase of 90.85.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 324.17. It has increased from 223.09 (Mar 23) to 324.17, marking an increase of 101.08.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 233.58. This value is within the healthy range. It has increased from 149.02 (Mar 23) to 233.58, marking an increase of 84.56.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 230.37. This value is within the healthy range. It has increased from 145.89 (Mar 23) to 230.37, marking an increase of 84.48.
  • For PBT / Share (Rs.), as of Mar 24, the value is 121.67. This value is within the healthy range. It has increased from 69.56 (Mar 23) to 121.67, marking an increase of 52.11.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 90.72. This value is within the healthy range. It has increased from 51.98 (Mar 23) to 90.72, marking an increase of 38.74.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 90.72. This value is within the healthy range. It has increased from 51.98 (Mar 23) to 90.72, marking an increase of 38.74.
  • For PBDIT Margin (%), as of Mar 24, the value is 72.05. This value is within the healthy range. It has increased from 66.79 (Mar 23) to 72.05, marking an increase of 5.26.
  • For PBIT Margin (%), as of Mar 24, the value is 71.06. This value exceeds the healthy maximum of 20. It has increased from 65.39 (Mar 23) to 71.06, marking an increase of 5.67.
  • For PBT Margin (%), as of Mar 24, the value is 37.53. This value is within the healthy range. It has increased from 31.18 (Mar 23) to 37.53, marking an increase of 6.35.
  • For Net Profit Margin (%), as of Mar 24, the value is 27.98. This value exceeds the healthy maximum of 10. It has increased from 23.30 (Mar 23) to 27.98, marking an increase of 4.68.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 27.98. This value exceeds the healthy maximum of 20. It has increased from 23.30 (Mar 23) to 27.98, marking an increase of 4.68.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 22.00. This value is within the healthy range. It has increased from 16.17 (Mar 23) to 22.00, marking an increase of 5.83.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 55.27. This value is within the healthy range. It has increased from 44.89 (Mar 23) to 55.27, marking an increase of 10.38.
  • For Return On Assets (%), as of Mar 24, the value is 5.01. This value is within the healthy range. It has increased from 3.77 (Mar 23) to 5.01, marking an increase of 1.24.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
  • For Total Debt / Equity (X), as of Mar 24, the value is 3.32. This value exceeds the healthy maximum of 1. It has increased from 3.19 (Mar 23) to 3.32, marking an increase of 0.13.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.20. It has increased from 0.18 (Mar 23) to 0.20, marking an increase of 0.02.
  • For Current Ratio (X), as of Mar 24, the value is 1.26. This value is below the healthy minimum of 1.5. There is no change compared to the previous period (Mar 23) which recorded 1.26.
  • For Quick Ratio (X), as of Mar 24, the value is 1.26. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.26.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 2.15. This value is below the healthy minimum of 3. It has increased from 1.95 (Mar 23) to 2.15, marking an increase of 0.20.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.83. This value is below the healthy minimum of 3. It has increased from 1.68 (Mar 23) to 1.83, marking an increase of 0.15.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 43,473.04. It has increased from 29,417.68 (Mar 23) to 43,473.04, marking an increase of 14,055.36.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.41. This value exceeds the healthy maximum of 3. It has increased from 8.30 (Mar 23) to 8.41, marking an increase of 0.11.
  • For EV / EBITDA (X), as of Mar 24, the value is 11.68. This value is within the healthy range. It has decreased from 12.42 (Mar 23) to 11.68, marking a decrease of 0.74.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 23) to 4.44, marking an increase of 0.34.
  • For Price / BV (X), as of Mar 24, the value is 3.49. This value exceeds the healthy maximum of 3. It has increased from 2.85 (Mar 23) to 3.49, marking an increase of 0.64.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.44. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 23) to 4.44, marking an increase of 0.34.
  • For EarningsYield, as of Mar 24, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of CreditAccess Grameen Ltd as of February 27, 2025 is: ₹1,605.20

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of February 27, 2025, CreditAccess Grameen Ltd is Undervalued by 59.09% compared to the current share price 1,009.00

Intrinsic Value of CreditAccess Grameen Ltd as of February 27, 2025 is: 2,041.67

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of February 27, 2025, CreditAccess Grameen Ltd is Undervalued by 102.35% compared to the current share price ₹1,009.00

Last 5 Year EPS CAGR: 27.19%

*Investments are subject to market risks

Strength and Weakness

Unable to fetch valid data for stock valuation.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CreditAccess Grameen Ltd:
    1. Net Profit Margin: 27.98%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 55.27% (Industry Average ROCE: 15.47%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 22% (Industry Average ROE: 22.27%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 1.83
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 1.26
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 18.3 (Industry average Stock P/E: 10.52)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 3.32
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

CreditAccess Grameen Ltd. is a Public Limited Listed company incorporated on 12/06/1991 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L51216KA1991PLC053425 and registration number is 053425. Currently company belongs to the Industry of Micro Finance Institutions. Company's Total Operating Revenue is Rs. 5166.67 Cr. and Equity Capital is Rs. 159.38 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Microfinance InstitutionsNo.49, 46th Cross, 8th Block, Bengaluru Karnataka 560071info@cagrameen.in
http://www.creditaccessgrameen.in
Management
NamePosition Held
Mr. George JosephChairman & Ind.Director
Mr. Paolo BrichettiVice Chairman & Non Exe.Dire
Mr. Udaya Kumar HebbarManaging Director & CEO
Ms. Rekha Gopal WarriarIndependent Director
Mr. Manoj KumarIndependent Director
Ms. Lilian Jessie PaulIndependent Director
Mr. Sumit KumarNominee Director
Mr. Massimo VitaNominee Director

FAQ

What is the latest intrinsic value of CreditAccess Grameen Ltd?

Let's break down CreditAccess Grameen Ltd's intrinsic value simply:

We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.

As of 27 February 2025:

  • Calculated Fair Value: ₹1605.20
  • Current Market Price: ₹1,009.00
  • Variance: 59.09% higher

This suggests CreditAccess Grameen Ltd is currently undervalued by 59.09%. For context:

  • Market Cap: 16,099 Cr.
  • 52-Week Range: 1,553/750
  • Reserves (Sep 2024): 6,829 Cr
  • Liabilities: 26,612 Cr

Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.

What is the Market Cap of CreditAccess Grameen Ltd?

The Market Cap of CreditAccess Grameen Ltd is 16,099 Cr..

What is the current Stock Price of CreditAccess Grameen Ltd as on 27 February 2025?

The current stock price of CreditAccess Grameen Ltd as on 27 February 2025 is ₹1,009.

What is the High / Low of CreditAccess Grameen Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of CreditAccess Grameen Ltd stocks is 1,553/750.

What is the Stock P/E of CreditAccess Grameen Ltd?

The Stock P/E of CreditAccess Grameen Ltd is 18.3.

What is the Book Value of CreditAccess Grameen Ltd?

The Book Value of CreditAccess Grameen Ltd is 438.

What is the Dividend Yield of CreditAccess Grameen Ltd?

The Dividend Yield of CreditAccess Grameen Ltd is 0.94 %.

What is the ROCE of CreditAccess Grameen Ltd?

The ROCE of CreditAccess Grameen Ltd is 14.8 %.

What is the ROE of CreditAccess Grameen Ltd?

The ROE of CreditAccess Grameen Ltd is 24.8 %.

What is the Face Value of CreditAccess Grameen Ltd?

The Face Value of CreditAccess Grameen Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in CreditAccess Grameen Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE